To keep pace with accelerated clinical development time frames, production complexities and demand, Matica Bio already has two collaborations at the new facility. The company is working with Sartorius to develop and optimize advanced viral vector manufacturing technologies for large-scale vector production.
Matica Bio has also partnered with Texas A&M University’s Center for Innovation in Advanced Development and Manufacturing for projects to speed up biotech R&D and commercial manufacturing.
>> Read the full article:
Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas